Ziprasidone Associated Neuroleptic Malignant Syndrome

Authors

  • Jeffrey D. Bell, M.D. University of Kansas School of Medicine-Wichita
  • Chancen Hall, D.O. University of Kansas School of Medicine-Wichita
  • Justin Sandall, D.O.

DOI:

https://doi.org/10.17161/kjm.vol1411970

Metrics

File downloads
473
Mar 19 '21Mar 22 '21Mar 25 '21Mar 28 '21Mar 31 '21Apr 01 '21Apr 04 '21Apr 07 '21Apr 10 '21Apr 13 '21Apr 16 '215.0
| |

Downloads

Published

2021-03-19

Issue

Vol. 14 No. 1 (2021): Jan. - Apr.

Section

Case Reports

License

Copyright (c) 2021 Jeffrey D. Bell, M.D., Chancen Hall, D.O., Justin Sandall, D.O.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Bell, J., Hall, C., & Sandall, J. (2021). Ziprasidone Associated Neuroleptic Malignant Syndrome. Kansas Journal of Medicine, 14(1), 82-83. https://doi.org/10.17161/kjm.vol1411970